These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10414411)

  • 21. Doppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patients.
    Cazzola M; Mantero A; Santus P; Carlucci P; Mondoni M; Bosotti L; Centanni S
    Pulm Pharmacol Ther; 2007; 20(3):258-64. PubMed ID: 16600647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
    Bjermer L; Rosenborg J; Bengtsson T; Lötvall J
    Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immediate bronchodilator response to formoterol in poorly reversible chronic obstructive pulmonary disease].
    Rubin AS; Souza FJ; Hetzel JL; Moreira Jda S
    J Bras Pneumol; 2008 Jun; 34(6):373-9. PubMed ID: 18622504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia.
    Cazzola M; Imperatore F; Salzillo A; Di Perna F; Calderaro F; Imperatore A; Matera MG
    Chest; 1998 Aug; 114(2):411-5. PubMed ID: 9726723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration.
    Lipworth BJ; Aziz I
    Chest; 2000 Jan; 117(1):156-62. PubMed ID: 10631214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease.
    Campbell M; Eliraz A; Johansson G; Tornling G; Nihlén U; Bengtsson T; Rabe KF
    Respir Med; 2005 Dec; 99(12):1511-20. PubMed ID: 16199148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study.
    Wadbo M; Löfdahl CG; Larsson K; Skoogh BE; Tornling G; Arweström E; Bengtsson T; Ström K;
    Eur Respir J; 2002 Nov; 20(5):1138-46. PubMed ID: 12449166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
    Aziz I; Lipworth BJ
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers.
    Palmqvist M; Arvidsson P; Beckman O; Peterson S; Lötvall J
    Pulm Pharmacol Ther; 2001; 14(1):29-34. PubMed ID: 11162416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol.
    Aziz I; Tan KS; Hall IP; Devlin MM; Lipworth BJ
    Eur Respir J; 1998 Sep; 12(3):580-4. PubMed ID: 9762783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A bolus of inhaled budesonide rapidly reverses airway subsensitivity and beta2-adrenoceptor down-regulation after regular inhaled formoterol.
    Aziz I; Lipworth BJ
    Chest; 1999 Mar; 115(3):623-8. PubMed ID: 10084466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Budesonide/formoterol: in chronic obstructive pulmonary disease.
    Reynolds NA; Perry CM; Keating GM
    Drugs; 2004; 64(4):431-41; discussion 433-4. PubMed ID: 14969576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double- blind, double-dummy, placebo- and active-controlled trial.
    Nelson HS; Gross NJ; Levine B; Kerwin EM; Rinehart M; Denis-Mize K;
    Clin Ther; 2007 Oct; 29(10):2167-78. PubMed ID: 18042473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced bronchospasm in athletes with asthma.
    Ferrari M; Balestreri F; Baratieri S; Biasin C; Oldani V; Lo Cascio V
    Respiration; 2000; 67(5):510-3. PubMed ID: 11070454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formoterol via Turbuhaler gave better protection than terbutaline against repeated exercise challenge for up to 12 hours in children and adolescents.
    Grönneröd TA; von Berg A; Schwabe G; Soliman S
    Respir Med; 2000 Jul; 94(7):661-7. PubMed ID: 10926337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dose-response study with formoterol Turbuhaler as maintenance therapy in asthmatic patients.
    Schreurs AJ; Sinninghe Damsté HE; de Graaff CS; Greefhorst AP
    Eur Respir J; 1996 Aug; 9(8):1678-83. PubMed ID: 8866594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease.
    Welte T; Miravitlles M; Hernandez P; Eriksson G; Peterson S; Polanowski T; Kessler R
    Am J Respir Crit Care Med; 2009 Oct; 180(8):741-50. PubMed ID: 19644045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD.
    Dahl R; Chung KF; Buhl R; Magnussen H; Nonikov V; Jack D; Bleasdale P; Owen R; Higgins M; Kramer B;
    Thorax; 2010 Jun; 65(6):473-9. PubMed ID: 20522841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.